David T. Doherty Sells 13,641 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY) CFO David T. Doherty sold 13,641 shares of the stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the sale, the chief financial officer now directly owns 108,862 shares in the company, valued at $2,787,955.82. This represents a 11.14 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Surgery Partners Trading Down 1.6 %

Shares of Surgery Partners stock opened at $25.35 on Thursday. The firm has a market capitalization of $3.22 billion, a PE ratio of -52.81, a P/E/G ratio of 17.77 and a beta of 2.60. Surgery Partners, Inc. has a twelve month low of $19.50 and a twelve month high of $35.29. The firm’s 50-day moving average price is $21.99 and its 200 day moving average price is $26.84. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.99.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.06). The company had revenue of $770.40 million during the quarter, compared to analysts’ expectations of $768.99 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company’s quarterly revenue was up 14.3% compared to the same quarter last year. During the same period in the prior year, the business posted $0.15 earnings per share. On average, sell-side analysts predict that Surgery Partners, Inc. will post 0.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on SGRY shares. Bank of America started coverage on Surgery Partners in a research report on Monday, December 16th. They set a “buy” rating and a $30.00 target price on the stock. Royal Bank of Canada dropped their target price on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 20th. JPMorgan Chase & Co. dropped their target price on Surgery Partners from $38.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 3rd. Finally, Macquarie restated an “outperform” rating and set a $34.00 target price on shares of Surgery Partners in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $36.56.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of SGRY. ExodusPoint Capital Management LP lifted its stake in Surgery Partners by 686.8% in the 4th quarter. ExodusPoint Capital Management LP now owns 182,300 shares of the company’s stock worth $3,859,000 after purchasing an additional 159,131 shares in the last quarter. Headlands Technologies LLC boosted its holdings in shares of Surgery Partners by 277.1% during the 4th quarter. Headlands Technologies LLC now owns 21,017 shares of the company’s stock worth $445,000 after purchasing an additional 15,443 shares during the last quarter. Cannell & Spears LLC acquired a new position in shares of Surgery Partners during the 4th quarter worth approximately $324,000. Norges Bank acquired a new position in shares of Surgery Partners during the 4th quarter worth approximately $15,796,000. Finally, Pier Capital LLC boosted its holdings in shares of Surgery Partners by 15.9% during the 4th quarter. Pier Capital LLC now owns 382,493 shares of the company’s stock worth $8,097,000 after purchasing an additional 52,611 shares during the last quarter.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.